SEC Stock Data Quick Answer ACRO BIOMEDICAL CO., LTD. reported Shares Outstanding of 60.04 million shares for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 60.04M +0.0% 2024 60.04M +0.0% 2023 60.04M +0.0% 2022 60.04M +0.0% 2021 60.04M +25.7% 2020 47.76M +0.0% 2019 47.76M +0.0% 2019 47.76M … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Gross Profit of $0.00 for fiscal year 2023. ACRO BIOMEDICAL CO., LTD. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2023 $0.00 -100.0% 2022 $140.5K -45.9% 2021 $259.5K +62.8% 2020 $159.4K +1217.8% 2019 $12.1K -91.1% 2019 $135.4K -83.8% 2018 $833.4K +1534.1% 2017 $51.0K — Quarterly … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Operating Income of -$154.0 thousand for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$154.0K -305.8% 2024 -$38.0K +99.6% 2023 -$8.80M +44.5% 2022 -$15.87M -106.3% 2021 -$7.69M -5797.1% 2020 -$130.5K +69.1% 2019 -$422.8K +4.3% 2019 -$441.6K -185.6% … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported R&D Expense of $0.00 for fiscal year 2024. ACRO BIOMEDICAL CO., LTD. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $0.00 -100.0% 2023 $4.79M -52.4% 2022 $10.08M +90.7% 2021 $5.29M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September 30, 2024 $0.00 … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Stockholders Equity of -$387.0 thousand for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 -$387.0K -31.2% 2024 -$295.0K -14.8% 2023 -$257.0K -152.8% 2022 $486.4K -24.4% 2021 $643.7K -6.1% 2020 $685.9K -14.1% 2019 $798.2K -8.6% 2019 $873.7K -25.2% … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Cash and Equivalents of $18.1 thousand for fiscal year 2020. ACRO BIOMEDICAL CO., LTD. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2020 $18.1K +1889.4% 2019 $911.00 -38.1% 2019 $1.5K -96.1% 2018 $37.6K +3175.9% 2018 $1.1K -96.9% 2017 $36.8K +1353.2% 2016 $2.5K -90.7% … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Total Assets of $14.1 thousand for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $14.1K -55.9% 2024 $32.0K -45.3% 2023 $58.5K -91.5% 2022 $687.5K -9.7% 2021 $761.1K -23.7% 2020 $998.1K +7.1% 2019 $932.1K -12.8% 2019 $1.07M -27.9% … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Diluted EPS of $0.00 per share for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $0.00 — 2024 $0.00 +100.0% 2023 -$0.15 +42.3% 2022 -$0.26 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September 30, … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Net Income of -$101.1 thousand for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$101.1K -139.1% 2024 -$42.3K +99.5% 2023 -$8.81M +44.5% 2022 -$15.87M -106.2% 2021 -$7.70M -6454.0% 2020 -$117.5K +68.4% 2019 -$371.6K -0.2% 2019 -$370.7K -188.3% … Read more
Quick Answer ACRO BIOMEDICAL CO., LTD. reported Total Revenue of $0.00 for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $0.00 — 2024 $0.00 — 2023 $0.00 -100.0% 2022 $658.5K -45.0% 2021 $1.20M — Quarterly Total Revenue Quarter Ending Total Revenue YoY QoQ September … Read more